SlideShare a Scribd company logo
1 of 34
GMP GUIDELINES FOR PREMISES
BUILDINGS AND FACILITIES
PREMISES

CONTENT                     Design and construction
 Principle                  features
 Facilities                Aseptic processing
 Ancillary area            Lighting
 Storage area              Plumbing
 Weighing area             Product Disposal
 Production area           Sanitation
 Quality Control Area      Maintenance
 Services                  References
Principle

Premises must be located, designed, constructed,
adapted and maintained for the operations:
  Minimize risks of errors and cross-contamination
  Permit effective cleaning
  Permit effective maintenance
  Minimize build-up of dirt and dust
  Eliminate any adverse effects on quality
PREMISES

         Principle
   Premises must be
    located to minimize
    risks of cross-
    contamination; e.g. not
    located next to a
    malting factory with
    high airborne levels of
    yeast
PREMISES

Arrival of goods         Visitors entrance         Workers entrance          Shipment of goods



       Material Flow C
                    Q                   Offices                    Canteen
                                                    Gowning
  Incoming
    goods                                                                    Shipping
People Flow                                                      Corridor
                        Corridor
                             Corridor
  Raw
Materials
                                                                 Packaging Finished
    &                                                 Filling              Products
Packaging Weighing              Processing
                                                                           Storage
 Storage

                        Washing          Machine
                                         Shop
                                                                       Corridor
                   Utilities and Services                       Waste Treatment
PREMISES

                            FACILITIES
 Adequate space for future expansion.
 Zoning laws – to allow anticipated development , restricting
  undesirable developments in the vicinity.
 Availability of water (quality and quantity) , power , fuel , sewage and
  waste – removal .
 Accessibility for employees, materials, and visitors
 Environmental issues such as site history ; soil , water , and air
  quality.
Proximity of undesirable activities likely to pollute.
 Availability of a suitable labor force (people , skill , wage expectations
  ,, access to further education sources).
 Ability to provide adequate security arrangements.
 Political situation - government stability, trade policies and taxation
  (for foreign - based operations), financial incentives.
PREMISES
    The site development plan will include
   Compliance with appropriate laws and regulations and any
    additional company standards.
   Site resources and infrastructure.
   Site security and access – fences , cameras .
   Buildings - sitting, layout, usage, function interrelationships for
    efficiency, possible expansion, surface finishes.
   Utilities – design, layout, backup (especially for critical utilities as
    electricity and nitrogen for some chemical operations).
   Equipment – design, layout , spares, capacity.
   Traffic flow – pedestrian and vehicular.
   Safety – for personnel and equipment, containment for hazardous
    materials, emergency egress.
   Ease of maintenance
PREMISES

                     ANCILLARY AREAS
   Rest and refreshment rooms should be separate from
    manufacturing and control areas.
   Facilities for changing and storing clothes and for washing
    and toilet purposes should be easily accessible and
    appropriate for the number of users. Toilets should not
    communicate directly with production or storage areas.
   Maintenance workshops should if possible be separated
    from production areas. Whenever parts and tools are stored
    in the production area,they should be kept in rooms or
    lockers reserved for that use.
   Animal houses should be well isolated from other areas, with
    separate entrance (animal access) and air-handling
    facilities.
PREMISES


                          AIR
                CHANGE
     FACTORY             LOCK
                 ROOM
                                TOILETS




               CANTEEN
PREMISES

                        Storage areas
   Storage areas should be of sufficient capacity to allow orderly
    storage of the various categories of materials and products with
    proper separation and segregation.

   Storage areas should be designed or adapted to ensure good
    storage conditions. In particular, they should be clean, dry,
    sufficiently lit and maintained within acceptable temperature
    limits.Special storage conditions - provided, controlled, monitored
    and recorded where appropriate.

   Receiving and dispatch batches should be separated and protect
    materials and products from the weather. Receiving areas should
    be designed and equipped to allow containers of incoming
    materials to be cleaned if necessary before storage.
PREMISES
   Where quarantine status is ensured by storage in separate areas,
    these areas must be clearly marked and their access restricted to
    authorized personnel.
   Segregation should be provided for the storage of rejected,
    recalled, or returned materials or products.
   Highly active and radioactive materials, narcotics, other dangerous
    drugs, and substances presenting special risks of abuse, fire or
    explosion should be stored in safe and secure areas.
   Printed packaging materials and labels – require safe and secure
    storage
   There should normally be a separate sampling area for starting
    materials. (If sampling is performed in the storage area, it should
    be conducted in such a way as to prevent contamination or cross-
    contamination.)
PREMISES
                    Weighing areas

   The weighing of starting materials and the
    estimation of yield by weighing should be carried
    out in separate weighing areas designed for that
    use.

   Such areas may be part of either storage or
    production areas.
PREMISES
                     Production areas
   In order to minimize the risk of a serious medical hazard
    due to cross-contamination, dedicated and self-contained
    facilities must be available for the production of particular
    pharmaceutical products, such as highly sensitizing
    materials (e.g. penicillin) or biological preparations (e.g.
    live microorganisms).

   The production of certain other highly active
    products, such as some antibiotics, hormones, cytotoxic
    substances       and      certain      non-pharmaceutical
    products, should not be conducted in the same facilities.

   The manufacture of technical poisons, such as pesticides
    and herbicides, should not be allowed in premises used for
    the manufacture of pharmaceutical products.
PREMISES

   Premises should preferably be laid out in such a way as to allow the
    production to take place in areas connected in a logical order
    corresponding to the sequence of the operations and to the requisite
    cleanliness levels.
   The adequacy of the working and in-process storage space should
    permit the orderly and logical positioning of equipment and materials
    so as to minimize the risk of confusion between different
    pharmaceutical products or their components, to avoid cross-
    contamination, and to minimize the risk of omission or wrong
    application of any of the manufacturing or control steps.
   Where starting and primary packaging materials and intermediate or
    bulk products are exposed to the environment, interior surfaces
    (walls, floors and ceilings) should be smooth and free from cracks
    and open joints, should not shed particulate matter.
PREMISES

 Pipe  work, light fittings, ventilation points
 Drains

 Effectively ventilated, with air-control
  facilities
 well lit
PREMISES
                  Quality control areas
   Quality control laboratories should be separated from production areas.
    Areas where biological, microbiological or radioisotope test methods
    are employed should be separated from each other.
   Quality control laboratories should be designed to suit the operations to
    be carried out in them. Sufficient space should be given to avoid mix-
    ups and cross-contamination.
   The design of the laboratories should take into account the suitability of
    construction materials, prevention of fumes and ventilation. There
    should be separate air supply to laboratories and production areas.
    Separate air-handling units and other provisions are needed for
    biological, microbiological and radio-isotope laboratories.
   A separate room may be needed for instruments to protect them
    against electrical interference, vibration, contact with excessive
    moisture and other external factors.
PREMISES

   Walls.

   Floors.

   Ceilings.

   Services.
TABLE 1 PROVIDES SOME GUIDANCE ON TYPICAL
FINISHES FOR VARIOUS OPERATIONS.

                                  TYPICAL FINISHES


                    WALLS                   FLOORS              CEILINGS

Warehouse           Painted                 HardenAed
                                            concrete, sealed
Dispensary          Epoxy coved             Epoxy or in situ    Epoxy coved
                                            terrazzo coved
Solids              Epoxy coved             Epoxy or in situ    Epoxy coved
manufacturing                               terrazzo coved
Liquids             Epoxy coved             Epoxy or in situ    Epoxy coved
manufacturing                               terrazzo coved
Solids packaging    Painted                 Sealed concrete,    Suspended ceiling
                                            terrazzo tile, or
                                            vinyl
Liquids packaging   Epoxy coved             Epoxy or in situ    Epoxy coved
(nonsterile)                                terrazzo coved
Laboratory          Epoxy                   Terrazzo tile or    Suspended ceiling
                                            epoxy sheet
PREMISES
                    Services

   In the building design, provisions must be made
    for drains, water, steam, electricity, and other
    services to allow for ease of maintenance.

    Access should be possible without disruption of
    activity within the actual rooms provided with
    the services.
PREMISES
        Design and construction features
   Any such building shall have adequate space for the
    Orderly placement of equipment and materials
   To prevent mix-ups between different components,
    drug        product containers, closures, labeling, in-
    process materials, or drug products.
   To prevent contamination.
   The flow of components, drug product containers,
    closures, labeling, in-process materials, and drug
    products through the building or buildings shall be
    designed to prevent contamination.
PREMISES
                 Aseptic processing
   Floors, walls, and ceilings of smooth, hard surfaces that are
    easily cleanable;
   Temperature and humidity controls;
   An air supply filtered through high-efficiency particulate air
    filters under positive pressure, regardless of whether flow is
    laminar or nonlaminar;
   A system for monitoring environmental conditions;
   A system for cleaning and disinfecting the room and equipment
    to produce aseptic conditions;
   A system for maintaining any equipment used to control the
    aseptic conditions.
PREMISES
                          Lighting

   Adequate lighting shall be provided in all area
   “ adequate “. Define the amount of light (lux or foot- candles)
    reaching the working surface for each area involved in the
    production of pharmaceuticals.
   Public standards exist for some type of work. Normally, a range
    of 30 – 50 foot – candles ensures worker comfort and have
    ability to perform efficiently and effectively, however, 100 foot-
    candles may be needed in some areas, as well as special
    lighting for some operations, such as inspection of filled vials.
PREMISES

  Ventilation, air filtration, air heating and cooling

(a)Adequate ventilation shall be provided.
(b)Equipment for adequate control over air pressure, micro-organisms, dust,
    humidity, and temperature shall be provided when appropriate for the
    manufacture, processing, packing, or holding of a drug product.
(c)Air filtration systems, including prefilters and particulate matter air filters,
    shall be used when appropriate on air supplies to production areas
 measures shall be taken to control recirculation of dust

 adequate exhaust systems ,dust extraction system.

(d) Air-handling systems for the manufacture, processing, and packing of
    penicillin shall be completely separate from those for other drug
    products for human use.
PREMISES

Air –handling systems should consider the following
factors:

   Placement of air inlet and outlet ports.
   Adequate precautions
   Temperature and humidity conditions should provide personnel
    comfort
   Where differential pressures are required between adjacent
    areas suitable monitoring equipment must be provided
   Siting of final air filters : Air usually enters rooms near the
    ceiling and leaves from the opposite side near the floor.
PREMISES
                              Plumbing
   Potable water shall be supplied under continuous positive pressure
    in a plumbing system free of defects that could contribute
    contamination to any drug product.

   Potable water shall meet the standards prescribed in the
    Environmental Protection Agency's

   Drains shall be of adequate size and, where connected directly to a
    sewer, shall be provided with an air break or other mechanical device
    to prevent back-siphonage.
PREMISES
                  Sewage and refuse

   Sewage, trash, and other refuse in and from the building
    and immediate premises shall be disposed of in a safe and
    sanitary manner.
   A pharmaceutical plant may consider disposal in several
    different ways :
   Product disposal
   Printed packaging disposal
   General trash and sewage
PREMISES
                     Product disposal
   Any product requiring disposal should initially be separated from
    its packaging if appropriate. For example, any product to be
    disposed of in an approved landfill site should not be left in
    impermeable glass, plastic, or other containers which would
    significantly delay destruction.

   There are risks associated with the destruction of products –
    potential for the product to get diverted and contamination of
    groundwater. Ideally, incineration procedures have preference over
    landfill. Where incineration is used, product in plastic or other
    flammable packaging may not need to be returned to bulk.
PREMISES

    Printed packaging disposal
   The disposal of printed packaging components including
    labels, inserts, and cartons poses no health risk. However, ineffective
    disposal , such as into public landfill, can give rise to public concern that
    product may be associated with the packaging. Such materials should
    preferably be incinerated.

    General trash and sewage
   Normal local services will usually be adequate for trash and sewage.
    However , internal procedures should be sufficiently monitored to ensure
    that product and packaging waste does not get intermixed. Containers
    used within the plant to accumulate waste materials should be clearly
    marked to denote their designated use.



PREMISES
            Washing and toilet facilities
   Adequate washing facilities shall be provided, including hot and
    cold water, soap or detergent, air driers or single-service towels,
    and clean toilet facilities easily accessible to working areas.

   In addition to GMP regulations, occupational safety & health
    administration (OSHA ) regulations impact on washing and toilet
    facilities. These require toilet rooms to be separate for each sex
    except where individual locked toilet rooms are available and
    also define the minimum number of water closets based on the
    number of users.
PREMISES
                      Sanitation
(a)Any building used in the manufacture, processing, packing, or
   holding of a drug product shall be maintained in a clean and
   sanitary condition, Any such building shall be free of infestation
   by rodents, birds, insects, and other vermin (other than
   laboratory animals).

(b)There shall be written procedures assigning responsibility for
   sanitation and describing in sufficient detail the cleaning
   schedules, methods, equipment, and materials to be used in
   cleaning the buildings and facilities; such written procedures
   shall be followed.
PREMISES
(c) There shall be written procedures for use of suitable
    rodenticides, insecticides, fungicides, fumigating agents, and
    cleaning and sanitizing agents .
 written procedures shall be designed and followed.

 Rodenticides, insecticides, and fungicides shall not be used
    unless registered and used in accordance with the Federal
    Insecticide, Fungicide, and Rodenticide Act .

(d) Sanitation procedures shall apply to work performed by
   contractors or temporary employees as well as work performed
   by full-time employees during the ordinary course of operations.
PREMISES
                      Maintenance

   Any building used in the
    manufacture, processing, packing, or holding of a drug
    product shall be maintained in a good state of repair
   Monitor cracks and holes in walls,floors and ceilings ;
    damage to insulation or pipes ; dust accumulation on light
    fittings etc.
   Building inspection and maintenance programs should be
    defined in writing and a record kept.
   Essential services will include
    water, steam, vacuum,compressed air and other
    gases, electricity, dust extraction, product/material pipe
    line, drainage.
REFERENCES

   Sidney H. willig, James R. stoker
    Good manufacturing practices for
    pharmaceuticals,volume 72,4th addition, page no:
     31
   http://whqlibdoc.who.int/trs/WHO_TRS_937_
    eng.pdf
   http://www.ich.org/cache/compo/276-254-1.html
   P.P.Sharma,How to practice GMPs,Vandana
    publication,Page no-163-187
Gmp premises 112070804006

More Related Content

What's hot

Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material managementTeny Thomas
 
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulolPilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulolKhushbooKunkulol
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004Patel Parth
 
Purchase specifications & Maintenance of stores For Raw materials
Purchase specifications & Maintenance of stores For Raw materialsPurchase specifications & Maintenance of stores For Raw materials
Purchase specifications & Maintenance of stores For Raw materialsYash Menghani
 
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCQUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCAnupriyaNR
 
In process & finished products quality control test for pharmaceuticals
In process & finished products quality control test for pharmaceuticalsIn process & finished products quality control test for pharmaceuticals
In process & finished products quality control test for pharmaceuticalsSuraj Ghorpade
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's typesAlexa Jacob
 
Quality control on secondary packaging materials
Quality control on secondary packaging materialsQuality control on secondary packaging materials
Quality control on secondary packaging materialsAnupriyaNR
 
Equipments and Raw Materials
Equipments and Raw MaterialsEquipments and Raw Materials
Equipments and Raw MaterialsTeny Thomas
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsSuraj Ghorpade
 
Process validation and its types
Process validation and its typesProcess validation and its types
Process validation and its typesAnjali9410
 
Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Nitin Kadam
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberKunalPatel257
 
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...Teny Thomas
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and controlMalay Pandya
 
APT Manufacturing Flowcharts.pptx
APT Manufacturing Flowcharts.pptxAPT Manufacturing Flowcharts.pptx
APT Manufacturing Flowcharts.pptxDhruvi50
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfTamannaKumari8
 

What's hot (20)

Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material management
 
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulolPilot plan scale up for semisolid and parenteral by Khushboo kunkulol
Pilot plan scale up for semisolid and parenteral by Khushboo kunkulol
 
cGMP.
cGMP.cGMP.
cGMP.
 
Good Warehousing Practices
Good Warehousing PracticesGood Warehousing Practices
Good Warehousing Practices
 
Glp 112070804004
Glp  112070804004Glp  112070804004
Glp 112070804004
 
Purchase specifications & Maintenance of stores For Raw materials
Purchase specifications & Maintenance of stores For Raw materialsPurchase specifications & Maintenance of stores For Raw materials
Purchase specifications & Maintenance of stores For Raw materials
 
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLCQUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
QUALIFICATION OF UV-VISIBLE SPECTROPHOTOMETER, FTIR, DSC, HPLC
 
In process & finished products quality control test for pharmaceuticals
In process & finished products quality control test for pharmaceuticalsIn process & finished products quality control test for pharmaceuticals
In process & finished products quality control test for pharmaceuticals
 
Pharmaceutical validation & it's types
 Pharmaceutical validation & it's types Pharmaceutical validation & it's types
Pharmaceutical validation & it's types
 
Quality control on secondary packaging materials
Quality control on secondary packaging materialsQuality control on secondary packaging materials
Quality control on secondary packaging materials
 
Equipments and Raw Materials
Equipments and Raw MaterialsEquipments and Raw Materials
Equipments and Raw Materials
 
BMR & MFR
BMR & MFRBMR & MFR
BMR & MFR
 
Pharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualificationsPharmaceutical validation, calibration & qualifications
Pharmaceutical validation, calibration & qualifications
 
Process validation and its types
Process validation and its typesProcess validation and its types
Process validation and its types
 
Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
 
Quality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubberQuality control test for packaging material ,qc test for glass,metal,rubber
Quality control test for packaging material ,qc test for glass,metal,rubber
 
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
 
APT Manufacturing Flowcharts.pptx
APT Manufacturing Flowcharts.pptxAPT Manufacturing Flowcharts.pptx
APT Manufacturing Flowcharts.pptx
 
General Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdfGeneral Principles of Analytical Method of Validation.pdf
General Principles of Analytical Method of Validation.pdf
 

Similar to Gmp premises 112070804006

Premises Design Construction And Plant
Premises Design Construction And PlantPremises Design Construction And Plant
Premises Design Construction And PlantPrakashKumar721
 
Quality Management System (QMS): Premises
Quality Management  System (QMS): PremisesQuality Management  System (QMS): Premises
Quality Management System (QMS): Premisessamahhamed3
 
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS Ravi Adhikari
 
FPL - 03 DESIGN, CONSTRUCTION.ppt
FPL - 03 DESIGN, CONSTRUCTION.pptFPL - 03 DESIGN, CONSTRUCTION.ppt
FPL - 03 DESIGN, CONSTRUCTION.ppthusnainrasheed123
 
Prerequisite Program (PRP).pptx
Prerequisite Program (PRP).pptxPrerequisite Program (PRP).pptx
Prerequisite Program (PRP).pptxPrasad Sambare
 
Guidance on good hygiene practices
Guidance on good hygiene practicesGuidance on good hygiene practices
Guidance on good hygiene practicesihn FreeStyle Corp.
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyPriyankaSananse
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxdrsriram2001
 
Plant site selection and layout
Plant site selection and layoutPlant site selection and layout
Plant site selection and layoutRobin Gulati
 
Schedule m(gmp)
Schedule m(gmp)Schedule m(gmp)
Schedule m(gmp)air981
 
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docx
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docxINSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docx
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docxJudithMutambo
 
Quali. & quan. layout sterile d.f sahil
Quali. & quan. layout sterile d.f sahilQuali. & quan. layout sterile d.f sahil
Quali. & quan. layout sterile d.f sahilsahilhusen
 

Similar to Gmp premises 112070804006 (20)

Premises Design Construction And Plant
Premises Design Construction And PlantPremises Design Construction And Plant
Premises Design Construction And Plant
 
Quality Management System (QMS): Premises
Quality Management  System (QMS): PremisesQuality Management  System (QMS): Premises
Quality Management System (QMS): Premises
 
Gmp
GmpGmp
Gmp
 
Gmp premicses
Gmp premicses Gmp premicses
Gmp premicses
 
Rekling10 gmp
Rekling10 gmpRekling10 gmp
Rekling10 gmp
 
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS
SELECTION OF SITE & PRECAUTIONS FOR HYGIENIC CONDITIONS
 
FPL - 03 DESIGN, CONSTRUCTION.ppt
FPL - 03 DESIGN, CONSTRUCTION.pptFPL - 03 DESIGN, CONSTRUCTION.ppt
FPL - 03 DESIGN, CONSTRUCTION.ppt
 
Prerequisite Program (PRP).pptx
Prerequisite Program (PRP).pptxPrerequisite Program (PRP).pptx
Prerequisite Program (PRP).pptx
 
GMP Sub Part - C
GMP Sub Part - CGMP Sub Part - C
GMP Sub Part - C
 
Guidance on good hygiene practices
Guidance on good hygiene practicesGuidance on good hygiene practices
Guidance on good hygiene practices
 
layout of buildings
layout of buildingslayout of buildings
layout of buildings
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technology
 
Sanitation
Sanitation Sanitation
Sanitation
 
MANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptxMANUFACTURING OF PARENTRALS.pptx
MANUFACTURING OF PARENTRALS.pptx
 
Plant site selection and layout
Plant site selection and layoutPlant site selection and layout
Plant site selection and layout
 
Schedule m(gmp)
Schedule m(gmp)Schedule m(gmp)
Schedule m(gmp)
 
Gmp
GmpGmp
Gmp
 
Pharmaceutical manufacturing plant
Pharmaceutical manufacturing plantPharmaceutical manufacturing plant
Pharmaceutical manufacturing plant
 
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docx
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docxINSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docx
INSPECTOR CHECKLIST FOR PROCESSING PLANT AND MASS CATERING.docx
 
Quali. & quan. layout sterile d.f sahil
Quali. & quan. layout sterile d.f sahilQuali. & quan. layout sterile d.f sahil
Quali. & quan. layout sterile d.f sahil
 

More from Patel Parth

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copyPatel Parth
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013Patel Parth
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us euPatel Parth
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Patel Parth
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oralPatel Parth
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Patel Parth
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarPatel Parth
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)Patel Parth
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Patel Parth
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical techniquePatel Parth
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage formsPatel Parth
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysisPatel Parth
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotechPatel Parth
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002Patel Parth
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014Patel Parth
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007Patel Parth
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001Patel Parth
 

More from Patel Parth (20)

Automated analysis by yatin sankharva copy
Automated analysis by yatin sankharva   copyAutomated analysis by yatin sankharva   copy
Automated analysis by yatin sankharva copy
 
Automated analysis 112070804013
Automated analysis 112070804013Automated analysis 112070804013
Automated analysis 112070804013
 
Anda registration in us eu
Anda registration in us  euAnda registration in us  eu
Anda registration in us eu
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009Analytical tech in pre formulation 112070804009
Analytical tech in pre formulation 112070804009
 
Analysis of solid oral
Analysis of solid oralAnalysis of solid oral
Analysis of solid oral
 
Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010Analysis of solid oral dosage forms 112070804010
Analysis of solid oral dosage forms 112070804010
 
Analysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminarAnalysis of parenteral dosage forms bjl final seminar
Analysis of parenteral dosage forms bjl final seminar
 
Analysis of data (pratik)
Analysis of data (pratik)Analysis of data (pratik)
Analysis of data (pratik)
 
Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018Analysis of cosmetics 112070804018
Analysis of cosmetics 112070804018
 
Agencies dhwani
Agencies dhwaniAgencies dhwani
Agencies dhwani
 
A seminar on applications of various analytical technique
A seminar on applications of various analytical techniqueA seminar on applications of various analytical technique
A seminar on applications of various analytical technique
 
23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms23117 copy of oral solid dosage forms
23117 copy of oral solid dosage forms
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
 
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech4003 regulatory aspect_of_bulk,pharmaceutical,biotech
4003 regulatory aspect_of_bulk,pharmaceutical,biotech
 
A.a sequence analysis 112070804002
A.a sequence analysis 112070804002A.a sequence analysis 112070804002
A.a sequence analysis 112070804002
 
Chi square test
Chi square testChi square test
Chi square test
 
Sterility testing 112070804014
Sterility testing 112070804014Sterility testing 112070804014
Sterility testing 112070804014
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007
 
Qc lab 112070804001
Qc lab 112070804001Qc lab 112070804001
Qc lab 112070804001
 

Gmp premises 112070804006

  • 1. GMP GUIDELINES FOR PREMISES BUILDINGS AND FACILITIES
  • 2. PREMISES CONTENT  Design and construction  Principle features  Facilities  Aseptic processing  Ancillary area  Lighting  Storage area  Plumbing  Weighing area  Product Disposal  Production area  Sanitation  Quality Control Area  Maintenance  Services  References
  • 3. Principle Premises must be located, designed, constructed, adapted and maintained for the operations:  Minimize risks of errors and cross-contamination  Permit effective cleaning  Permit effective maintenance  Minimize build-up of dirt and dust  Eliminate any adverse effects on quality
  • 4. PREMISES Principle  Premises must be located to minimize risks of cross- contamination; e.g. not located next to a malting factory with high airborne levels of yeast
  • 5. PREMISES Arrival of goods Visitors entrance Workers entrance Shipment of goods Material Flow C Q Offices Canteen Gowning Incoming goods Shipping People Flow Corridor Corridor Corridor Raw Materials Packaging Finished & Filling Products Packaging Weighing Processing Storage Storage Washing Machine Shop Corridor Utilities and Services Waste Treatment
  • 6. PREMISES FACILITIES  Adequate space for future expansion.  Zoning laws – to allow anticipated development , restricting undesirable developments in the vicinity.  Availability of water (quality and quantity) , power , fuel , sewage and waste – removal .  Accessibility for employees, materials, and visitors  Environmental issues such as site history ; soil , water , and air quality. Proximity of undesirable activities likely to pollute.  Availability of a suitable labor force (people , skill , wage expectations ,, access to further education sources).  Ability to provide adequate security arrangements.  Political situation - government stability, trade policies and taxation (for foreign - based operations), financial incentives.
  • 7. PREMISES The site development plan will include  Compliance with appropriate laws and regulations and any additional company standards.  Site resources and infrastructure.  Site security and access – fences , cameras .  Buildings - sitting, layout, usage, function interrelationships for efficiency, possible expansion, surface finishes.  Utilities – design, layout, backup (especially for critical utilities as electricity and nitrogen for some chemical operations).  Equipment – design, layout , spares, capacity.  Traffic flow – pedestrian and vehicular.  Safety – for personnel and equipment, containment for hazardous materials, emergency egress.  Ease of maintenance
  • 8. PREMISES ANCILLARY AREAS  Rest and refreshment rooms should be separate from manufacturing and control areas.  Facilities for changing and storing clothes and for washing and toilet purposes should be easily accessible and appropriate for the number of users. Toilets should not communicate directly with production or storage areas.  Maintenance workshops should if possible be separated from production areas. Whenever parts and tools are stored in the production area,they should be kept in rooms or lockers reserved for that use.  Animal houses should be well isolated from other areas, with separate entrance (animal access) and air-handling facilities.
  • 9. PREMISES AIR CHANGE FACTORY LOCK ROOM TOILETS CANTEEN
  • 10. PREMISES Storage areas  Storage areas should be of sufficient capacity to allow orderly storage of the various categories of materials and products with proper separation and segregation.  Storage areas should be designed or adapted to ensure good storage conditions. In particular, they should be clean, dry, sufficiently lit and maintained within acceptable temperature limits.Special storage conditions - provided, controlled, monitored and recorded where appropriate.  Receiving and dispatch batches should be separated and protect materials and products from the weather. Receiving areas should be designed and equipped to allow containers of incoming materials to be cleaned if necessary before storage.
  • 11. PREMISES  Where quarantine status is ensured by storage in separate areas, these areas must be clearly marked and their access restricted to authorized personnel.  Segregation should be provided for the storage of rejected, recalled, or returned materials or products.  Highly active and radioactive materials, narcotics, other dangerous drugs, and substances presenting special risks of abuse, fire or explosion should be stored in safe and secure areas.  Printed packaging materials and labels – require safe and secure storage  There should normally be a separate sampling area for starting materials. (If sampling is performed in the storage area, it should be conducted in such a way as to prevent contamination or cross- contamination.)
  • 12. PREMISES Weighing areas  The weighing of starting materials and the estimation of yield by weighing should be carried out in separate weighing areas designed for that use.  Such areas may be part of either storage or production areas.
  • 13. PREMISES Production areas  In order to minimize the risk of a serious medical hazard due to cross-contamination, dedicated and self-contained facilities must be available for the production of particular pharmaceutical products, such as highly sensitizing materials (e.g. penicillin) or biological preparations (e.g. live microorganisms).  The production of certain other highly active products, such as some antibiotics, hormones, cytotoxic substances and certain non-pharmaceutical products, should not be conducted in the same facilities.  The manufacture of technical poisons, such as pesticides and herbicides, should not be allowed in premises used for the manufacture of pharmaceutical products.
  • 14. PREMISES  Premises should preferably be laid out in such a way as to allow the production to take place in areas connected in a logical order corresponding to the sequence of the operations and to the requisite cleanliness levels.  The adequacy of the working and in-process storage space should permit the orderly and logical positioning of equipment and materials so as to minimize the risk of confusion between different pharmaceutical products or their components, to avoid cross- contamination, and to minimize the risk of omission or wrong application of any of the manufacturing or control steps.  Where starting and primary packaging materials and intermediate or bulk products are exposed to the environment, interior surfaces (walls, floors and ceilings) should be smooth and free from cracks and open joints, should not shed particulate matter.
  • 15. PREMISES  Pipe work, light fittings, ventilation points  Drains  Effectively ventilated, with air-control facilities  well lit
  • 16. PREMISES Quality control areas  Quality control laboratories should be separated from production areas. Areas where biological, microbiological or radioisotope test methods are employed should be separated from each other.  Quality control laboratories should be designed to suit the operations to be carried out in them. Sufficient space should be given to avoid mix- ups and cross-contamination.  The design of the laboratories should take into account the suitability of construction materials, prevention of fumes and ventilation. There should be separate air supply to laboratories and production areas. Separate air-handling units and other provisions are needed for biological, microbiological and radio-isotope laboratories.  A separate room may be needed for instruments to protect them against electrical interference, vibration, contact with excessive moisture and other external factors.
  • 17. PREMISES  Walls.  Floors.  Ceilings.  Services.
  • 18. TABLE 1 PROVIDES SOME GUIDANCE ON TYPICAL FINISHES FOR VARIOUS OPERATIONS. TYPICAL FINISHES WALLS FLOORS CEILINGS Warehouse Painted HardenAed concrete, sealed Dispensary Epoxy coved Epoxy or in situ Epoxy coved terrazzo coved Solids Epoxy coved Epoxy or in situ Epoxy coved manufacturing terrazzo coved Liquids Epoxy coved Epoxy or in situ Epoxy coved manufacturing terrazzo coved Solids packaging Painted Sealed concrete, Suspended ceiling terrazzo tile, or vinyl Liquids packaging Epoxy coved Epoxy or in situ Epoxy coved (nonsterile) terrazzo coved Laboratory Epoxy Terrazzo tile or Suspended ceiling epoxy sheet
  • 19. PREMISES Services  In the building design, provisions must be made for drains, water, steam, electricity, and other services to allow for ease of maintenance.  Access should be possible without disruption of activity within the actual rooms provided with the services.
  • 20. PREMISES Design and construction features  Any such building shall have adequate space for the Orderly placement of equipment and materials  To prevent mix-ups between different components, drug product containers, closures, labeling, in- process materials, or drug products.  To prevent contamination.  The flow of components, drug product containers, closures, labeling, in-process materials, and drug products through the building or buildings shall be designed to prevent contamination.
  • 21. PREMISES Aseptic processing  Floors, walls, and ceilings of smooth, hard surfaces that are easily cleanable;  Temperature and humidity controls;  An air supply filtered through high-efficiency particulate air filters under positive pressure, regardless of whether flow is laminar or nonlaminar;  A system for monitoring environmental conditions;  A system for cleaning and disinfecting the room and equipment to produce aseptic conditions;  A system for maintaining any equipment used to control the aseptic conditions.
  • 22. PREMISES Lighting  Adequate lighting shall be provided in all area  “ adequate “. Define the amount of light (lux or foot- candles) reaching the working surface for each area involved in the production of pharmaceuticals.  Public standards exist for some type of work. Normally, a range of 30 – 50 foot – candles ensures worker comfort and have ability to perform efficiently and effectively, however, 100 foot- candles may be needed in some areas, as well as special lighting for some operations, such as inspection of filled vials.
  • 23. PREMISES Ventilation, air filtration, air heating and cooling (a)Adequate ventilation shall be provided. (b)Equipment for adequate control over air pressure, micro-organisms, dust, humidity, and temperature shall be provided when appropriate for the manufacture, processing, packing, or holding of a drug product. (c)Air filtration systems, including prefilters and particulate matter air filters, shall be used when appropriate on air supplies to production areas  measures shall be taken to control recirculation of dust  adequate exhaust systems ,dust extraction system. (d) Air-handling systems for the manufacture, processing, and packing of penicillin shall be completely separate from those for other drug products for human use.
  • 24. PREMISES Air –handling systems should consider the following factors:  Placement of air inlet and outlet ports.  Adequate precautions  Temperature and humidity conditions should provide personnel comfort  Where differential pressures are required between adjacent areas suitable monitoring equipment must be provided  Siting of final air filters : Air usually enters rooms near the ceiling and leaves from the opposite side near the floor.
  • 25. PREMISES Plumbing  Potable water shall be supplied under continuous positive pressure in a plumbing system free of defects that could contribute contamination to any drug product.  Potable water shall meet the standards prescribed in the Environmental Protection Agency's  Drains shall be of adequate size and, where connected directly to a sewer, shall be provided with an air break or other mechanical device to prevent back-siphonage.
  • 26. PREMISES Sewage and refuse  Sewage, trash, and other refuse in and from the building and immediate premises shall be disposed of in a safe and sanitary manner.  A pharmaceutical plant may consider disposal in several different ways :  Product disposal  Printed packaging disposal  General trash and sewage
  • 27. PREMISES Product disposal  Any product requiring disposal should initially be separated from its packaging if appropriate. For example, any product to be disposed of in an approved landfill site should not be left in impermeable glass, plastic, or other containers which would significantly delay destruction.  There are risks associated with the destruction of products – potential for the product to get diverted and contamination of groundwater. Ideally, incineration procedures have preference over landfill. Where incineration is used, product in plastic or other flammable packaging may not need to be returned to bulk.
  • 28. PREMISES Printed packaging disposal  The disposal of printed packaging components including labels, inserts, and cartons poses no health risk. However, ineffective disposal , such as into public landfill, can give rise to public concern that product may be associated with the packaging. Such materials should preferably be incinerated. General trash and sewage  Normal local services will usually be adequate for trash and sewage. However , internal procedures should be sufficiently monitored to ensure that product and packaging waste does not get intermixed. Containers used within the plant to accumulate waste materials should be clearly marked to denote their designated use. 
  • 29. PREMISES Washing and toilet facilities  Adequate washing facilities shall be provided, including hot and cold water, soap or detergent, air driers or single-service towels, and clean toilet facilities easily accessible to working areas.  In addition to GMP regulations, occupational safety & health administration (OSHA ) regulations impact on washing and toilet facilities. These require toilet rooms to be separate for each sex except where individual locked toilet rooms are available and also define the minimum number of water closets based on the number of users.
  • 30. PREMISES Sanitation (a)Any building used in the manufacture, processing, packing, or holding of a drug product shall be maintained in a clean and sanitary condition, Any such building shall be free of infestation by rodents, birds, insects, and other vermin (other than laboratory animals). (b)There shall be written procedures assigning responsibility for sanitation and describing in sufficient detail the cleaning schedules, methods, equipment, and materials to be used in cleaning the buildings and facilities; such written procedures shall be followed.
  • 31. PREMISES (c) There shall be written procedures for use of suitable rodenticides, insecticides, fungicides, fumigating agents, and cleaning and sanitizing agents .  written procedures shall be designed and followed.  Rodenticides, insecticides, and fungicides shall not be used unless registered and used in accordance with the Federal Insecticide, Fungicide, and Rodenticide Act . (d) Sanitation procedures shall apply to work performed by contractors or temporary employees as well as work performed by full-time employees during the ordinary course of operations.
  • 32. PREMISES Maintenance  Any building used in the manufacture, processing, packing, or holding of a drug product shall be maintained in a good state of repair  Monitor cracks and holes in walls,floors and ceilings ; damage to insulation or pipes ; dust accumulation on light fittings etc.  Building inspection and maintenance programs should be defined in writing and a record kept.  Essential services will include water, steam, vacuum,compressed air and other gases, electricity, dust extraction, product/material pipe line, drainage.
  • 33. REFERENCES  Sidney H. willig, James R. stoker Good manufacturing practices for pharmaceuticals,volume 72,4th addition, page no: 31  http://whqlibdoc.who.int/trs/WHO_TRS_937_ eng.pdf  http://www.ich.org/cache/compo/276-254-1.html  P.P.Sharma,How to practice GMPs,Vandana publication,Page no-163-187